These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 7650329)

  • 1. [Reduction of the number of amniocentesis screenings for trisomy 21 in women younger than 38 using plasma hCG and ultrasonography. Results of a study].
    Vauthier-Brouzes D; Lefebvre G; Sebagh E; Choukroun JB; Bernard M; Lesourd S; Darbois Y
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(4):454-5. PubMed ID: 7650329
    [No Abstract]   [Full Text] [Related]  

  • 2. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost-benefit analysis of prenatal screening for trisomy 21 through analysis of HCG in maternal blood].
    Seror V; Moatti JP; Muller F; Le Galès C; Boué A
    Rev Epidemiol Sante Publique; 1993; 41(1):3-15. PubMed ID: 8465062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the association of a serum marker and second trimester ultrasonography for the screening of trisomy 21 in women of less than 38 years. Prospective study of 5,163 patients].
    Lefebvre G; Vauthier-Brouzes D; Choukroun JB; Sebagh E; Bernard M; Brochet C; Lesourd S; Darbois Y
    J Gynecol Obstet Biol Reprod (Paris); 1998 Oct; 27(6):599-604. PubMed ID: 9854223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcomes of women with positive serum screening results for Down syndrome and trisomy 18.
    Summers AM; Huang T; Wyatt PR
    Prenat Diagn; 2002 Mar; 22(3):269-71. PubMed ID: 11920909
    [No Abstract]   [Full Text] [Related]  

  • 8. The sensitivity of the trivariate analysis using maternal serum alpha-feto protein, human chorionic gonadotrophin and maternal age in screening for fetal aneuploidy in mothers above the age of 35.
    Anandakumar C; Chew S; Wong YC; Goh VH; Tain CF; Ratnam SS
    J Perinat Med; 1999; 27(3):178-82. PubMed ID: 10503178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Triple screening for trisomy 21: prospective results of 7039 assessments].
    Pescia G; Dao MH; Weihs D; Gaide AC; Loertscher A; Hohlfeld P; Marguerat P; Nguyen The H; Paccaud F; Maillard C
    Rev Med Suisse Romande; 1993 Apr; 113(4):277-80. PubMed ID: 7684852
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Valencia C; Maiz N; Nicolaides KH
    Hum Reprod; 2008 Sep; 23(9):1968-75. PubMed ID: 18544579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late first-trimester invasive prenatal diagnosis: results of an international randomized trial.
    Philip J; Silver RK; Wilson RD; Thom EA; Zachary JM; Mohide P; Mahoney MJ; Simpson JL; Platt LD; Pergament E; Hershey D; Filkins K; Johnson A; Shulman LP; Bang J; MacGregor S; Smith JR; Shaw D; Wapner RJ; Jackson LG;
    Obstet Gynecol; 2004 Jun; 103(6):1164-73. PubMed ID: 15172848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum screening and trisomy 16 confined to the placenta.
    Groli C; Cerri V; Tarantini M; Bellotti D; Jacobello C; Gianello R; Zanini R; Lancetti S; Zaglio S
    Prenat Diagn; 1996 Aug; 16(8):685-9. PubMed ID: 8878276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum screening for trisomy 21 in women with a false positive result in last pregnancy.
    Abdul-Hamid S; Fox R; Martin I
    J Obstet Gynaecol; 2004 Jun; 24(4):374-6. PubMed ID: 15203574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies.
    Bindra R; Heath V; Liao A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2002 Sep; 20(3):219-25. PubMed ID: 12230441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low second-trimester maternal serum human chorionic gonadotrophin in a trisomy 9 pregnancy.
    Lam YH; Lee CP; Tang MH
    Prenat Diagn; 1998 Nov; 18(11):1212. PubMed ID: 9854737
    [No Abstract]   [Full Text] [Related]  

  • 18. Amniocentesis and chorionic villus sampling.
    Shulman LP; Elias S
    West J Med; 1993 Sep; 159(3):260-8. PubMed ID: 8236967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
    Biggio JR; Morris TC; Owen J; Stringer JS
    Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetoplacental and fetoamniotic chromosomal discrepancies in prenatally detected mosaic trisomy 9.
    Chen CP; Chern SR; Town DD; Wang W; Liao YW
    Prenat Diagn; 2003 Dec; 23(12):1019-21. PubMed ID: 14663842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.